In vitro NHBE model of the human bronchial epithelium for toxicological testing

The respiratory tract is the primary site of exposure to inhaled substances. A growing need exists for high throughput in vitro models of the respiratory epithelium, which can provide rapid, reliable safety and effective screening in preclinical drug development applications. Normal human bronchial...

Full description

Bibliographic Details
Main Author: Prytherch, Zoe
Published: Cardiff University 2010
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.584944
id ndltd-bl.uk-oai-ethos.bl.uk-584944
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-5849442015-03-20T03:21:21ZIn vitro NHBE model of the human bronchial epithelium for toxicological testingPrytherch, Zoe2010The respiratory tract is the primary site of exposure to inhaled substances. A growing need exists for high throughput in vitro models of the respiratory epithelium, which can provide rapid, reliable safety and effective screening in preclinical drug development applications. Normal human bronchial epithelial (NHBE) cells were cultured at an air-liquid interface in order to produce an in vitro model of the respiratory epithelium for toxicological testing. Extensive biochemical and morphological characterisation during construct development revealed that the NHBE model formed a pseudo-stratified, fully-differentiated culture of muco-ciliary phenotype. Histochemical and immunohistochemical techniques allowed the identification of basal, Clara, goblet and ciliated cells. Developmental characterisation revealed a toxicological dosing window of 7 days, where the model was deemed to be fully-established. Fully-developed NHBE cultures were then exposed to classical pulmonary toxicants (CPT) Lipopolysaccharide, cadmium chloride, paraquat, Amiodarone and cigarette smoke. Conventional toxicology techniques (culture viability, trans-epithelial electrical resistance TEER and morphology) were utilised to monitor the NHBE response to each CPT. The NHBE model responded with both general and toxicant-specific defence/irritancy mechanisms, observed to take place in the human bronchial epithelium and as such, reflective of in vivo toxicity. The in vitro model was finally challenged with candidate respiratory drugs (AstraZeneca AZ ) to test the utility of the cell system as a drug pre-screening tool. Blind-exposure of AZ compounds were characterised (physicochemical/ biochemically/morphologically) in the in vitro model and compared to AZ in vivo (rat) parallel exposure, focusing on irritancy end-points. A comparison of in vitro to in vivo exposures resulted in a 76.9 - 85% correlation of irritancy responses.615.9Cardiff Universityhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.584944http://orca.cf.ac.uk/54972/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 615.9
spellingShingle 615.9
Prytherch, Zoe
In vitro NHBE model of the human bronchial epithelium for toxicological testing
description The respiratory tract is the primary site of exposure to inhaled substances. A growing need exists for high throughput in vitro models of the respiratory epithelium, which can provide rapid, reliable safety and effective screening in preclinical drug development applications. Normal human bronchial epithelial (NHBE) cells were cultured at an air-liquid interface in order to produce an in vitro model of the respiratory epithelium for toxicological testing. Extensive biochemical and morphological characterisation during construct development revealed that the NHBE model formed a pseudo-stratified, fully-differentiated culture of muco-ciliary phenotype. Histochemical and immunohistochemical techniques allowed the identification of basal, Clara, goblet and ciliated cells. Developmental characterisation revealed a toxicological dosing window of 7 days, where the model was deemed to be fully-established. Fully-developed NHBE cultures were then exposed to classical pulmonary toxicants (CPT) Lipopolysaccharide, cadmium chloride, paraquat, Amiodarone and cigarette smoke. Conventional toxicology techniques (culture viability, trans-epithelial electrical resistance TEER and morphology) were utilised to monitor the NHBE response to each CPT. The NHBE model responded with both general and toxicant-specific defence/irritancy mechanisms, observed to take place in the human bronchial epithelium and as such, reflective of in vivo toxicity. The in vitro model was finally challenged with candidate respiratory drugs (AstraZeneca AZ ) to test the utility of the cell system as a drug pre-screening tool. Blind-exposure of AZ compounds were characterised (physicochemical/ biochemically/morphologically) in the in vitro model and compared to AZ in vivo (rat) parallel exposure, focusing on irritancy end-points. A comparison of in vitro to in vivo exposures resulted in a 76.9 - 85% correlation of irritancy responses.
author Prytherch, Zoe
author_facet Prytherch, Zoe
author_sort Prytherch, Zoe
title In vitro NHBE model of the human bronchial epithelium for toxicological testing
title_short In vitro NHBE model of the human bronchial epithelium for toxicological testing
title_full In vitro NHBE model of the human bronchial epithelium for toxicological testing
title_fullStr In vitro NHBE model of the human bronchial epithelium for toxicological testing
title_full_unstemmed In vitro NHBE model of the human bronchial epithelium for toxicological testing
title_sort in vitro nhbe model of the human bronchial epithelium for toxicological testing
publisher Cardiff University
publishDate 2010
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.584944
work_keys_str_mv AT prytherchzoe invitronhbemodelofthehumanbronchialepitheliumfortoxicologicaltesting
_version_ 1716780480235307008